NCT03393884: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 130 planned
- Started
- 5 Sep 2018
- Primary completion
- 25 Jul 2024
- Arms
- NACT + IMNN-001
- Results
- None posted
- 9 Jan 2018: Trial registered
- 5 Sep 2018: Trial started